CHPA Applauds Georgia's Adoption of Real-Time, Stop Sale Technology to Prevent Illegal Sales of Pseudoephedrine

Share page:

(WASHINGTON, D.C.) — Today, the Consumer Healthcare Products Association (CHPA) applauds the state of Georgia for becoming the thirty-third state to adopt the real-time, stop-sale technology called the National Precursor Log Exchange (NPLEx), a blocking system used across the country which prevents the illegal sale of pseudoephedrine (PSE), an ingredient sometimes used in the production of methamphetamine. Aside from blocking illegal sales at the pharmacy counter, the NPLEx system provides law enforcement with valuable, real-time data on potential criminal activity. The legislation – sponsored by state Representative Clark and Senator Unterman – was approved by the Georgia Legislature and signed by Governor Nathan Deal on April 26, 2016.

NPLEx is a proven tool in the fight against PSE diversion across the country. The system helps to prevent purchases by potential meth criminals while protecting law-abiding consumers’ access to safe and effective medicines containing PSE, such as Advil Cold & Sinus, Allegra-D, Claritin-D, Mucinex D, and Sudafed. Georgia is the last state in the southeast to adopt NPLEx, as all of its neighboring states – South Carolina, Florida, Alabama, Tennessee and North Carolina – adopted the system in previous years.

“CHPA commends the leadership of the Georgia Legislature and Governor Nathan Deal in the adoption of NPLEx and their participation in this successful national effort in the fight against meth,” said Scott Melville, president and chief executive officer of CHPA. “We also applaud legislators, law enforcement and pharmacists across all thirty-three states working together to stop the illegal diversion of PSE, while ensuring that law-abiding citizens continue to have access to these safe and effective nonprescription cold and allergy medicines.”

The announcement comes on the heels of a recent report from the National Association of Drug Diversion Investigators (NADDI) showing that so far this year between January 1, 2016 to March 31, 2016, that NPLEx has blocked the illegal sale of 395,394 boxes of medicine containing PSE, keeping 1,018,259 grams of PSE out of the hands of criminals. 

The Consumer Healthcare Products Association (CHPA), founded in 1881, is the national trade association representing the leading manufacturers and marketers of consumer healthcare products, including over-the-counter (OTC) medicines, dietary supplements, and consumer medical devices. CHPA is committed to empowering self-care by ensuring that Americans have access to products they can count on to be reliable, affordable, and convenient, while also delivering new and better ways to get and stay healthy. Visit